Skip to search formSkip to main contentSkip to account menu

Foradil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Inhaled Corticosteroids and LABAs In December, the FDA removed the boxed warning on combination products containing an inhaled… 
2004
2004
In order to characterize the efficacy of dry powder inhalers, in vitro measurements are much easier to perform than human… 
2004
2004
Background: For maximum treatment compliance there is a need to provide asthma patients with devices that suit their particular… 
2004
2004
Objective: To assess the peak inspiratory flow rate (PIFR) and forced inspiratory vital capacity (FIVC) through the formoterol… 
Review
2004
Review
2004
Evaluation of patients with chronic obstructive pulmonary disease (COPD) often includes the use of post‐bronchodilator… 
2002
2002
AbstractObjective: At the time of marketing, experience of long-term use of prescription medicines in general clinical practice… 
Highly Cited
2001
Highly Cited
2001
Formoterol fumarate is a beta2-agonist bronchodilator that combines a fast onset of action with a long duration of action. Its… 
Highly Cited
1999
Highly Cited
1999
AbstractObjective: The pharmacokinetics of the long-acting β2-agonist formoterol fumarate, which is a racemate of the (S,S)- and… 
1999
1999
OBJECTIVE The pharmacokinetics of the long-acting beta2-agonist formoterol fumarate, which is a racemate of the (S,S)- and (R,R…